Detalhe da pesquisa
1.
Anemia diagnosis and therapy in malignant diseases: implementation of guidelines-a representative study.
Support Care Cancer
; 32(2): 113, 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240843
2.
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306.
Eur Radiol
; 33(2): 1174-1184, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976398
3.
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer.
Support Care Cancer
; 31(10): 581, 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728795
4.
[Anemia: Diagnostics and Therapy]. / Ambulante Anämiediagnostik und -therapie.
Anasthesiol Intensivmed Notfallmed Schmerzther
; 58(4): 213-230, 2023 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-37044106
5.
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
Int J Cancer
; 150(1): 112-123, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431518
6.
Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.
Support Care Cancer
; 30(6): 5187-5200, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35257229
7.
A comparative assessment of neutropenia events, healthcare resource use, and costs among cancer patients treated with lipegfilgrastim compared with pegfilgrastim in Germany.
Support Care Cancer
; 30(11): 9317-9327, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36076105
8.
Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
Support Care Cancer
; 29(5): 2519-2527, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32944800
9.
Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany.
Support Care Cancer
; 28(5): 2175-2184, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410600
10.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514803
11.
G-CSF guideline adherence in Germany, an update with a retrospective and representative sample survey.
Support Care Cancer
; 27(4): 1459-1469, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30374765
12.
Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors.
Support Care Cancer
; 27(7): 2569-2577, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30443809
13.
Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
Int J Cancer
; 142(5): 1047-1055, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29047142
14.
Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase.
Ann Hematol
; 96(9): 1463-1470, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28725989
15.
Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF).
Support Care Cancer
; 30(9): 7067-7077, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35739328
16.
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.
Support Care Cancer
; 25(11): 3295-3304, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28842778
17.
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
N Engl J Med
; 369(2): 111-21, 2013 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23841729
18.
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.
Ann Hematol
; 95(6): 967-72, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26994010
19.
Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy--a representative sample survey in Germany.
Support Care Cancer
; 24(1): 367-376, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26081593
20.
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Lancet Oncol
; 16(16): 1691-9, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26549589